Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
View Study [4]"Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wasting" Levolger S, Wiemer EAC, et al., 2019 Finding: LR3 IGF-I treatment effectively limited muscle mass loss in a cancer cachexia model, demonstrating its potent anti-catabolic effects and ability to preserve muscle tissue under conditions that normally cause severe muscle wasting
If youre ready to regain your youth and vitality, call (281) 313-7435 to schedule your private consultation today
10.1038/nrd2368 25 CeciA.ConteR.DidioA.BonifaziD.FelisiM.GiannuzziV.et al (2019)
PubMed laboratory research record [PMID: 32226643] PubMed record related to this compound for laboratory literature review
Sobo may be appropriate
US$ 20.76
US$ 21.08
US$ 24.26
US$ 26.36
US$ 26.24
US$ 20.75
